Homomeric and heteromeric ampa receptors
CA 2378151 A1 · Owner: Boehringer Ingelheim International Gmbh · Inventors: Nishimura, Seiichiro; Iizuka, Masaki; Barsoumian, Edward Leon
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides cell lines expressing a recombinant heteromeric AMPA glutamate receptor, preferably a human heteromeric AMPA glutamate receptor, or a recombinant human homomeric AMPA glutamate receptor. The invention also provides methods for preparing said cell lines. The invention furthermore pertains to the use of said cell lines for the identification of glutamate receptor agonists, antagonists or modulators and methods for the identification of said agonists, antagonists or modulators. The invention also provides pharmaceutical compositions comprising said agonists antagonists or , modulators. The invention furthermore is concerned with the use of agonists …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 29, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 29, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 29, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.